Your browser doesn't support javascript.
loading
Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.
Lope, Virginia; Guerrero-Zotano, Ángel; Fernández de Larrea-Baz, Nerea; Antolín, Silvia; Benavent Viñuales, Marta; Bermejo, Begoña; Ruiz-Moreno, Emma; Baena-Cañada, José Manuel; París, Lorena; Antón, Antonio; Chacón, José Ignacio; Muñoz, Montserrat; García-Sáenz, José Angel; Olier, Clara; Sánchez Rovira, Pedro; Arcusa Lanza, Angels; González, Sonia; Brunet, Joan; Oltra, Amparo; Bezares, Susana; Rosell, Libertad; Pérez-Gómez, Beatriz; Pastor-Barriuso, Roberto; Martín, Miguel; Pollán, Marina.
Afiliación
  • Lope V; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
  • Guerrero-Zotano Á; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Instituto Valenciano de Oncología, Valencia, Spain.
  • Fernández de Larrea-Baz N; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
  • Antolín S; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Complejo Hospitalario de La Coruña (CHUAC), La Coruña, Spain.
  • Benavent Viñuales M; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
  • Bermejo B; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Clínico de Valencia, Biomedical Research Institut INCLIVA, Medicine Department, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.
  • Ruiz-Moreno E; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
  • Baena-Cañada JM; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain.
  • París L; Centro Oncológico de Galicia, La Coruña, Spain.
  • Antón A; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Miguel Servet, Instituto Investigación Sanitaria Aragon, Departamento Medicina Universidad de Zaragoza, Zaragoza, Spain.
  • Chacón JI; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Toledo, Toledo, Spain.
  • Muñoz M; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clinic i Provincial de Barcelona, FRCB-Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Department of Medicine, University of Barcelona, Barcelona, Spain.
  • García-Sáenz JA; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
  • Olier C; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital de Alcorcón, Madrid, Spain.
  • Sánchez Rovira P; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Jaén, Jaén, Spain.
  • Arcusa Lanza A; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Consorci Sanitari de Terrassa, Barcelona, Spain.
  • González S; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Mutua Terrassa, Barcelona, Spain.
  • Brunet J; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Institut Català d'Oncologia, Hospital Josep Trueta, Oncogir, IDIBGI, Girona, Spain.
  • Oltra A; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Virgen de los Lirios, Alicante, Spain.
  • Bezares S; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
  • Rosell L; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
  • Pérez-Gómez B; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
  • Pastor-Barriuso R; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
  • Martín M; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.
  • Pollán M; Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spa
J Nutr Health Aging ; 28(8): 100312, 2024 Jul 05.
Article en En | MEDLINE | ID: mdl-38970849
ABSTRACT

OBJECTIVES:

Adherence to healthy lifestyle recommendations has been reported to improve health-related quality of life (HRQL) in breast cancer (BC) patients, but the influence of long-term behavioral changes remains unknown. We evaluated the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations and HRQL both, at BC diagnosis and the change 7-12 years later.

DESIGN:

Prospective cohort study. SETTINGS AND

PARTICIPANTS:

A total of 406 breast cancer survivors, from the EpiGEICAM study, were recruited in 16 Spanish hospitals. MEASUREMENTS Epidemiological, clinical, dietary, physical activity and HRQL information was collected both at recruitment and 7-12 years later. A 7-item score to measure compliance with recommendations was assessed according to the 2018 WCRF/AICR scoring criteria. HRQL was evaluated using SF-36 questionnaire. Linear mixed models for longitudinal data were used to assess the cross-sectional and longitudinal association between adherence score and the physical and mental component summary scores.

RESULTS:

At diagnosis, for each unit increase in WCRF/AICR score adherence, the HRQL physical domain increased 0.78 points (95%CI -0.04 to 1.60; P trend0.06). The mean change in physical HRQL from diagnosis to follow-up per unit increase in within-subject adherence score was 0.73 points (95%CI -0.18 to 1.65; P trend 0.12). For the mental domain, no association was observed with compliance with the recommendations at diagnosis, nor with changes in adherence over time.

CONCLUSIONS:

Our results suggest that Increased adherence to WCRF/AICR cancer prevention recommendations over time could contribute to slightly improved long-term physical HRQoL in BC survivors.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Nutr Health Aging Asunto de la revista: CIENCIAS DA NUTRICAO / GERIATRIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Nutr Health Aging Asunto de la revista: CIENCIAS DA NUTRICAO / GERIATRIA Año: 2024 Tipo del documento: Article